🔴 MRNA is trading 4.1% down today in a pullback from recent strength

MRNA is trading 4.1% down at $78.45 as the stock pulls back from a sharp run-up over the prior week.

• There is no clear company-specific news catalyst for the move, suggesting a technical reversal after the stock traded near $81.80 on July 06.
• Broader market sentiment is adding pressure to growth and biotech shares, with the NASDAQ Composite down 1.00%.
• The current decline represents a notable intraday shift following the recent period of outperformance.